Kenya National Cancer Control Programme (NCCP) Implementation Guide - Local Development build (v1.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
CodeSystem: Kenya Medication Clinical Category Code System
Codes classifying the clinical role of a medication within an oncology regimen.
This Code system is referenced in the definition of the following value sets:
This case-sensitive code system https://fhir.dha.go.ke/terminology/CodeSystem/med-clinical-category-cs defines the following codes:
| Code | Display | Definition |
| CHEMOTHERAPY |
Chemotherapy |
Cytotoxic agent used to kill or inhibit cancer cells. |
| IMMUNOTHERAPY |
Immunotherapy |
Agent that stimulates the immune system against cancer. |
| TARGETED-THERAPY |
Targeted Therapy |
Agent targeting specific molecular markers on cancer cells. |
| HORMONAL-THERAPY |
Hormonal Therapy |
Agent that blocks or modifies hormone-driven tumour growth. |
| SUPPORTIVE-CARE |
Supportive Care |
Medication to manage side effects or improve tolerability. |
| ANTI-EMETIC |
Anti-emetic |
Agent to prevent or treat nausea and vomiting. |
| GROWTH-FACTOR |
Growth Factor |
Colony-stimulating factor to support blood cell recovery. |
| CORTICOSTEROID |
Corticosteroid |
Steroid given as part of or to support the oncology regimen. |
| BISPHOSPHONATE |
Bisphosphonate |
Agent for prevention or treatment of bone metastasis. |
| ANALGESIC |
Analgesic |
Pain management medication in the cancer care context. |
Description of the above table(s).